Granite Bay Wealth Management’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-7,394
Closed -$205K 78
2024
Q1
$205K Sell
7,394
-457,021
-98% -$12.7M 0.12% 75
2023
Q4
$14M Buy
464,415
+357
+0.1% +$10.8K 0.13% 69
2023
Q3
$16.4M Buy
+464,058
New +$16.4M 0.16% 65
2023
Q2
Sell
-8,286
Closed -$338K 65
2023
Q1
$338K Sell
8,286
-160
-2% -$6.91K 0.24% 52
2022
Q4
$433K Buy
8,446
+3,655
+76% +$175K 0.28% 39
2022
Q3
$210K Sell
4,791
-300
-6% -$14.6K 0.17% 56
2022
Q2
$267K Buy
5,091
+120
+2% +$6.12K 0.21% 45
2022
Q1
$257K Hold
4,971
0.21% 52
2021
Q4
$294K Buy
+4,971
New +$246K 0.29% 45

Other funds holding PFE

Granite Bay Wealth Management's PFE Position: Q2 2024 in Review

Granite Bay Wealth Management sold out of Pfizer (PFE) in Q2 2024, closing a stake of 7,394 shares — an estimated $205K sold.

Granite Bay Wealth Management first reported a position in PFE in Q4 2021 and held it in 9 quarters. The position peaked at $16.4M in Q3 2023. 2,873 funds tracked by Wall St. Rank hold PFE as of Q2 2024.

  • Granite Bay Wealth Management reported no remaining Pfizer position as of Q2 2024 after selling out during the quarter.
  • Granite Bay Wealth Management sold 7,394 Pfizer shares in Q2 2024, an estimated $205K.
  • Granite Bay Wealth Management first reported a position in Pfizer in Q4 2021 and held it in 9 quarters.
  • Granite Bay Wealth Management's Pfizer position peaked at $16.4M in Q3 2023.
  • 2,873 funds tracked by Wall St. Rank held Pfizer as of Q2 2024.

Based on Granite Bay Wealth Management's 13F filing for Q2 2024, filed 15 Jul 2024.